Yunxin Lai

Title: Innovations of Yunxin Lai in Chimeric Antigen Receptors

Introduction

Yunxin Lai is a prominent inventor based in Shenzhen, China. He has made significant contributions to the field of biomedical technology, particularly in the development of chimeric antigen receptors. His work focuses on enhancing the efficacy of treatments for tumors through innovative receptor designs.

Latest Patents

Yunxin Lai holds a patent for a chimeric antigen receptor containing a toll-like receptor intracellular domain. This invention relates to a chimeric antigen receptor, a nucleic acid encoding the same, and a cell expressing the same, which are utilized in manufacturing drugs for treating tumors. The chimeric antigen receptor is characterized by its intracellular domain, which includes at least Toll-like receptor 1 and/or Toll-like receptor 2 intracellular domain(s). Compared to prior art, this invention offers significant advantages in T cell expansion, cytotoxicity, T cell invasion and migration, eliminating the immunosuppressive effect of regulatory T cells, and promoting the formation of memory T cells.

Career Highlights

Yunxin Lai is associated with Shenzhen in Vivo Biomedicine Technology Limited Company, where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the field of immunotherapy.

Collaborations

Yunxin collaborates with notable colleagues, including Peng Li and Simiao Lin, who contribute to his research endeavors and help drive forward the advancements in chimeric antigen receptor technology.

Conclusion

Yunxin Lai's contributions to the field of biomedical technology, particularly through his patented innovations, highlight his role as a leading inventor in the development of effective tumor treatments. His work continues to pave the way for future advancements in immunotherapy.